Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

357
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
357
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

686
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
686
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.6K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

286
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
286
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

151
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
151
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.4K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Chou's 5-steps rule to predict the subcellular localization of gram-negative and gram-positive bacterial proteins by multi-label learning based on gene ontology annotation and profile alignment.

Journal of integrative bioinformatics·2020
Same author

Profiles and majority voting-based ensemble method for protein secondary structure prediction.

Evolutionary bioinformatics online·2011
See all related articles

Related Experiment Video

Updated: Oct 27, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K

Logistic matrix factorisation and generative adversarial neural network-based method for predicting drug-target

Sarra Itidal Abbou1, Hafida Bouziane2, Abdallah Chouarfia2

  • 1Department of Computer Sciences, Faculty of Mathematics and Computer Sciences, University of Science and Technology of Oran, Mohamed Boudiaf USTO-MB, Oran Mnaouer, P.O. Box: 1505, 31000, Oran, Algeria. sarraitidel.abbou@univ-usto.dz.

Molecular Diversity
|July 23, 2021
PubMed
Summary

This study introduces a novel computational method for predicting drug-target interactions, significantly improving accuracy by integrating matrix factorization and generative adversarial networks (GANs) for enhanced drug discovery.

Keywords:
Deep learningDrug repurposingDrug-target interaction (DTI)Generative adversarial networks (GAN)Latent interaction featuresLogistic matrix factorisation

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Related Experiment Videos

Last Updated: Oct 27, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.0K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.4K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Drug discovery

Background:

  • Accurate drug-target interaction prediction is vital for efficient drug discovery.
  • Existing computational models often analyze drug and target features separately, missing crucial interaction information.
  • Traditional wet-lab methods for identifying drug-target pairs are resource-intensive.

Purpose of the Study:

  • To develop an advanced computational method for predicting drug-target protein association pairs.
  • To overcome limitations of existing models by extracting joint interaction features.
  • To enhance prediction accuracy and efficiency in drug discovery and repurposing.

Main Methods:

  • A three-step approach combining matrix factorization and a generative adversarial network (GAN).
  • Matrix factorization extracts joint interaction features from the drug-target interaction matrix.
  • GAN is employed for data augmentation, generating synthetic positive samples to balance datasets and improve prediction accuracy.
  • A four-layer fully connected neural network is utilized for final classification.

Main Results:

  • The proposed method achieved prediction accuracy exceeding 97%, outperforming shallow classifiers and state-of-the-art techniques.
  • Experimental results confirmed the effectiveness of the data generation step in improving prediction performance.
  • Latent interaction features and data augmentation were shown to be efficient for predicting new drug-target associations and drug repurposing.

Conclusions:

  • The developed method offers a highly accurate and efficient approach for drug-target interaction prediction.
  • The integration of matrix factorization and GANs provides a robust framework for leveraging interaction data.
  • This approach holds significant potential for accelerating drug discovery and repurposing efforts.